References
- Imbimbo BP, Imbimbo E, Daniotti S, et al. A new criterion for selection of pharmacokinetic multiexponential equations. J Pharm Sci 1988;77:784–9
- Imbimbo BP, Martinelli P, Rocchetti M, et al. Efficiency of different criteria for selecting pharmacokinetic multiexponential equations. Biopharm Drug Dispos 1991;12:139–47
- Ludden TM, Beal SL, Sheiner LB. Comparison of the Akaike Information Criterion, the Schwarz criterion and the F test as guides to model selection. J Pharmacokinet Biopharm 1994;22:431–45
- Eksborg S. Evaluation of method-comparison data. Clin Chem 1981;27:1311–12
- Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 1981;9:503–12
- Eksborg S, Ehrsson H. Calibration curves: calculation and evaluation of accuracy. Ther Drug Monit 1994;16:629–30
- Eksborg S, Albertioni F, Beck O, et al. Methotrexate in rheumatoid arthritis-a limited sampling strategy for estimation of the area under the plasma concentration versus time curve. Ther Drug Monit 1994;16:560–3
- Lönnqvist PA, Bergendahl H. Pharmacokinetics and haemodynamic response after an intravenous bolus injection of clonidine in children. Paediatr Anaesth 1993;3:359–64
- Eksborg S, Pal N, Kalin M, et al. Pharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherapy: can intravenous acyclovir be substituted by oral valacyclovir? Med Pediatr Oncol 2002;38:240–6
- Ivani G, Bergendahl HT, Lampugnani E, et al. Plasma levels of clonidine following epidural bolus injection in children. Acta Anaesthesiol Scand 1998;42:306–11
- Debord J, Pessis C, Voultoury JC, et al. Population pharmacokinetics of amikacin in intensive care unit patients studied by NPEM algorithm. Fundam Clin Pharmacol 1995;9:57–61
- Burtin P, Jacqz-Aigrain E, Girard P, et al. Population pharmacokinetics of midazolam in neonates. Clin Pharmacol Ther 1994;56:615–25
- Rodvold KA, Gentry CA, Plank GS, et al. Bayesian forecasting of serum vancomycin concentrations in neonates and infants. Ther Drug Monit 1995;17:239–46
- Riad LE, Chan KK, Wagner WE, Jr., et al. Simultaneous first- and zero-order absorption of carbamazepine tablets in humans. J Pharm Sci 1986;75:897–900
- Holford NH, Ambros RJ, Stoeckel K. Models for describing absorption rate and estimating extent of bioavailability: application to cefetamet pivoxil. J Pharmacokinet Biopharm 1992;20:421–42
- Ferron GM, Rochdi M, Jusko WJ, et al. Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses. J Clin Pharmacol 1996;36:874–83
- Wu G. Calculating predictive performance: a user's note. Pharmacol Res 1995;31:393–9
- Wu G, Baraldo M, Furlanut M. Calculating percentage prediction error: a user's note. Pharmacol Res 1995;32:241–8
- Samara E, Granneman R. Role of population pharmacokinetics in drug development. A pharmaceutical industry perspective. Clin Pharmacokinet 1997;32:294–312
- Kauffman RE, Kearns GL. Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations. Clin Pharmacokinet 1992;23:10–29
- Willis C, Staatz CE, Tett SE. Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients. Ther Drug Monit 2003;25:158–66
- Gilman JT. Therapeutic drug monitoring in the neonate and paediatric age group – problems and clinical pharmacokinetic implications. Clin Pharmacokinet 1990;19:1–10
- Piotrovskij VK. Statistics or pharmacokinetics? Clin Pharmacokinet 1994;26:82–3
- Sun H, Ette EI, Ludden TM. On the recording of sampling times and parameter estimation from repeated measures pharmacokinetic data. J Pharmacokinet Biopharm 1996;24:637–50
- Roberts RJ. Intravenous administration of medication in pediatric patients: problems and solutions. Pediatr Clin North Am 1981;28:23–34
- Wang X, Tin SK. Population pharmacokinetics model validation using Kinetica™. Annual Meeting of the Population Approach Group in Europe, 2002. Paris, France. Abstr 343.
- Ette EI, Ludden TM. Population pharmacokinetic modeling: the importance of informative graphics. Pharm Res 1995;12:1845–55